Medtronic Current Ratio Growth & History (MDT)
Medtronic's current ratio was 2.13 for fiscal 2026.
View full Medtronic company overviewMedtronic annual current ratio history
| Fiscal year | Period ended | Current ratio | Change | Growth |
|---|---|---|---|---|
| 2026 | 2026-04-24 | 2.13 | 0.28 | +14.99% |
| 2025 | 2025-04-25 | 1.85 | −0.18 | −9.05% |
| 2024 | 2024-04-26 | 2.03 | −0.36 | −15.10% |
| 2023 | 2023-04-28 | 2.39 | 0.53 | +28.72% |
| 2022 | 2022-04-29 | 1.86 | −0.79 | −29.79% |
| 2021 | 2021-04-30 | 2.65 | 0.52 | +24.68% |
| 2020 | 2020-04-24 | 2.13 | −0.47 | −18.03% |
| 2019 | 2019-04-26 | 2.59 | 0.31 | +13.78% |
| 2018 | 2018-04-27 | 2.28 | 0.54 | +30.69% |
| 2017 | 2017-04-28 | 1.74 | −1.55 | −47.06% |
| 2016 | 2016-04-29 | 3.29 | −0.07 | −2.04% |
| 2015 | 2015-04-24 | 3.36 | −0.45 | −11.87% |
| 2014 | 2014-04-25 | 3.82 | — | — |
Medtronic quarterly current ratio
| Fiscal quarter | Period ended | Current ratio | Change | YoY change |
|---|---|---|---|---|
| Q1 2027 | 2026-07-31 | 2.07 | 0.05 | +2.63% |
| Q4 2026 | 2026-04-24 | 2.13 | 0.28 | +14.99% |
| Q3 2026 | 2026-01-31 | 2.54 | 0.63 | +33.33% |
| Q3 2026 | 2026-01-23 | 2.54 | 0.63 | +33.33% |
| Q2 2026 | 2025-10-24 | 2.42 | 0.58 | +31.27% |
| Q1 2026 | 2025-07-25 | 2.01 | −0.12 | −5.59% |
| Q4 2025 | 2025-04-25 | 1.85 | −0.18 | −9.05% |
| Q3 2025 | 2025-01-24 | 1.90 | −0.40 | −17.29% |
| Q2 2025 | 2024-10-25 | 1.84 | −0.45 | −19.51% |
| Q1 2025 | 2024-07-26 | 2.13 | −0.28 | −11.74% |
| Q4 2024 | 2024-04-26 | 2.03 | −0.36 | −15.10% |
| Q3 2024 | 2024-01-26 | 2.30 | 0.54 | +30.71% |
| Q2 2024 | 2023-10-27 | 2.29 | 0.53 | +30.20% |
| Q1 2024 | 2023-07-28 | 2.42 | 0.84 | +53.42% |
| Q4 2023 | 2023-04-28 | 2.39 | 0.53 | +28.72% |
| Q3 2023 | 2023-01-27 | 1.76 | −0.85 | −32.63% |
| Q2 2023 | 2022-10-28 | 1.76 | −1.16 | −39.73% |
| Q1 2023 | 2022-07-29 | 1.58 | −1.31 | −45.47% |
| Q4 2022 | 2022-04-29 | 1.86 | −0.79 | −29.79% |
| Q3 2022 | 2022-01-28 | 2.61 | 0.51 | +24.18% |
| Q2 2022 | 2021-10-29 | 2.91 | 0.76 | +35.06% |
| Q1 2022 | 2021-07-30 | 2.89 | 1.02 | +54.28% |
| Q4 2021 | 2021-04-30 | 2.65 | 0.52 | +24.68% |
| Q3 2021 | 2021-01-29 | 2.10 | −0.65 | −23.63% |
| Q2 2021 | 2020-10-30 | 2.16 | −0.62 | −22.21% |
| Q1 2021 | 2020-07-31 | 1.87 | −0.79 | −29.74% |
| Q4 2020 | 2020-04-24 | 2.13 | −0.47 | −18.03% |
| Q3 2020 | 2020-01-24 | 2.75 | 0.39 | +16.72% |
| Q2 2020 | 2019-10-25 | 2.77 | 0.21 | +8.37% |
| Q1 2020 | 2019-07-26 | 2.67 | 0.20 | +8.14% |
| Q4 2019 | 2019-04-26 | 2.59 | 0.31 | +13.78% |
| Q3 2019 | 2019-01-25 | 2.36 | −0.08 | −3.10% |
| Q2 2019 | 2018-10-26 | 2.56 | 0.16 | +6.73% |
| Q1 2019 | 2018-07-27 | 2.46 | 0.83 | +50.68% |
| Q4 2018 | 2018-04-27 | 2.28 | 0.54 | +30.69% |
| Q3 2018 | 2018-01-26 | 2.43 | 0.66 | +37.53% |
| Q2 2018 | 2017-10-27 | 2.40 | 0.05 | +2.18% |
| Q1 2018 | 2017-07-28 | 1.64 | −1.34 | −45.03% |
| Q4 2017 | 2017-04-28 | 1.74 | −1.55 | −47.06% |
| Q3 2017 | 2017-01-27 | 1.77 | −1.62 | −47.75% |
| Q2 2017 | 2016-10-28 | 2.35 | −1.19 | −33.62% |
| Q1 2017 | 2016-07-29 | 2.98 | −0.83 | −21.79% |
| Q4 2016 | 2016-04-29 | 3.29 | −0.07 | −2.04% |
| Q3 2016 | 2016-01-29 | 3.39 | — | — |
| Q2 2016 | 2015-10-30 | 3.53 | — | — |
| Q1 2016 | 2015-07-31 | 3.81 | — | — |
| Q4 2015 | 2015-04-24 | 3.36 | −0.45 | −11.87% |
| Q4 2014 | 2014-04-25 | 3.82 | — | — |
Medtronic current ratio trends
Over the last five fiscal years, Medtronic's current ratio decreased from 2.65 to 2.13, a change of −0.52. The latest reported quarter, Q1 2027, shows 2.07.
What the current ratio means
The current ratio compares short-term assets with obligations due within roughly one year. A higher ratio generally indicates more short-term balance-sheet coverage, but normal levels vary by industry and business model.
How the current ratio is calculated
TickerStat calculates the current ratio as SEC-reported current assets divided by SEC-reported current liabilities for the same balance-sheet date. Periods without a positive current-liability value are omitted. Fiscal periods can differ from calendar years, so exact period-end dates are included.
Review Medtronic source filings ↗Community posts
Medtronic begins European clinical use of its Stealth AXiS surgical system
Medtronic ($MDT) announced the first European procedures using its Stealth AXiS surgical system, with more than 23 procedures performed across seven sites in Germany, the UK, Italy and Spain. The initial experience includes spinal surgery. ...